COVID-19 risk might be much lower than in past summers, but it’s not gone - making a pre-Christmas booster for some a good idea.

Video above: FDA votes to authorize more COVID-19 boosters, mix-and-matching doses in some casesA booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — ...

With the Delta variant in play, federal health officials are analyzing the latest numbers to look at the frequency and seriousness of COVID-19 breakthrough infections. Will we need booster shots? And ...

Experts are concerned about a potential viral resurgence this fall, winter. With the end of summer nearing, and Labor Day around the corner, U.S. health officials are preparing to roll out millions of ...

A third dose of the Pfizer vaccine is currently authorized for Americans who received their second dose at least six months ago and are ages 65 and older, have a job that increases their risk of ...

A Food and Drug Administration (FDA) advisory panel voted 18-0 to authorize a Pfizer booster shot for Americans 65 years and older and those at risk of severe COVID-19 infection. The panel also voted ...

LONDON - Johnson & Johnson’s booster dose of its vaccine was found to be 94% effective against symptomatic COVID-19 in the United States when administered two months after the first shot, the company ...

Researchers at University of Tsukuba have demonstrated that during Japan's COVID-19 booster vaccination campaign, online ...

The US Centers for Disease Control and Prevention strengthened recommendations for booster doses of coronavirus vaccine Monday, saying all adults should get boosted six months after the second dose of ...

UK data show fear of COVID-19, male gender and prior booster history predict vaccination intention, while message framing has ...